Welcome to our dedicated page for Leidos Holdings SEC filings (Ticker: LDOS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Leidos’ filings aren’t just long—they’re layered with classified contract language, labyrinthine cost-plus fee schedules, and segment realignments that can reshape revenue overnight. If you have ever searched for “Leidos SEC filings explained simply” or wished for a shortcut to decipher a 300-page risk section, you are in the right place.
Stock Titan’s AI reads every disclosure the instant it hits EDGAR, then translates it into clear takeaways. Want the latest Leidos quarterly earnings report 10-Q filing broken down by Defense, Civil, and Health profits? Done. Need alerts on Leidos Form 4 insider transactions real-time so you can spot buying ahead of contract awards? They arrive within seconds. Our platform also surfaces:
- Leidos annual report 10-K simplified—segment backlog drivers, classified revenue exposure, and pension obligations.
- Leidos proxy statement executive compensation—how incentive pay ties to mission wins and cost controls.
- Leidos 8-K material events explained—from bid protest results to cyber incident disclosures.
Every page includes AI-powered summaries, side-by-side metric comparisons, and keyword search so you can move from question to answer quickly—whether you ask, “How is Leidos funding its R&D?” or “Where do I find Leidos executive stock transactions Form 4?”
Finish research faster: track Leidos insider trading Form 4 transactions, run instant Leidos earnings report filing analysis, and keep understanding Leidos SEC documents with AI—all updated in real time and available without navigating EDGAR’s maze.
Leidos Holdings, Inc. (LDOS) filed a Form 144 reporting a proposed sale under Rule 144 and listing recent insider sales. The notice states 12,497 shares of common stock are to be sold through Citigroup Global Markets, Inc. on 09/04/2025, with an aggregate market value of $2,227,590.00 and 128,297,332 shares outstanding. The filing shows these shares were acquired on 09/04/2025 by restricted stock vesting/stock option exercise and paid with cash/services rendered. The filer also reported two prior sales in the past three months: 7,526 shares on 08/08/2025 for $1,327,477.00 and 12,890 shares on 08/20/2025 for $2,297,945.00. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
Noel B. Geer, a director of Leidos Holdings, Inc. (LDOS), exercised stock options and corrected a prior Form 4 attribution error. The filing reports an option exercise on 08/27/2025 that resulted in acquisition of 3,345 shares at an exercise price of $75.02 per share. After the transaction the report shows total beneficial ownership of 37,018.8435 shares, comprised of 37,018.8435 shares directly (adjusted) with 2,000 shares held indirectly by spouse and 32,000 shares held indirectly by a Family Trust. The filing also corrects a November 8, 2023 Form 4 to reclassify a prior sale of 2,106 shares from indirect Family Trust ownership to direct ownership by the reporting person.
Roy E. Stevens, a Sector President and reporting officer of Leidos Holdings, Inc. (LDOS), recorded option exercises and related share movements on 08/25/2025. He exercised stock options with a $62.43 exercise price, resulting in acquisition of 7,536 common shares. To cover the exercise price and fees, 4,820 shares were withheld by the issuer. Separately, 2,716 shares were sold at a weighted average price of $181.6634. After these transactions, the reporting person beneficially owned 49,934 shares directly and 1,784.3897 shares indirectly under a Key Executive Stock Deferral Plan. The Form 4 was signed by power of attorney on 08/27/2025.
Leidos Holdings, Inc. (LDOS) Form 144 notice: An individual proposes to sell 2,750 shares of Leidos common stock through Citigroup Global Markets, Inc. on 08/25/2025. The filing states an aggregate market value of $499,574.35 and reports 128,297,332 shares outstanding for the issuer. The filer indicates the shares were acquired and sold on 08/25/2025 via an option exercise and sale, with payment in cash. No other securities were reported sold by the person in the prior three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Leidos Holdings insider sale reported. Stephen Edward Hull, Sector President and reporting officer, sold 12,890 shares of Leidos Holdings, Inc. (LDOS) on 08/20/2025 at a weighted-average price of $178.2735 per share. After the sale, the filing reports he beneficially owned 26,369.9809 shares. The Form 4 was submitted under power of attorney by Ramune M. Kligys and dated 08/22/2025. The filing notes the sale occurred in multiple transactions at prices ranging from $178.03 to $178.69 and that the reporting person will provide detailed per-price quantities upon request.
Leidos Holdings, Inc. (LDOS) Form 144 notice shows a proposed sale of 12,890 shares of common stock to be executed on 08/20/2025 through Citigroup Global Markets, Inc. The filer reports these shares were acquired the same day by restricted stock vesting from Leidos and the consideration is listed as services rendered.
The filing also discloses a recent sale within the past three months: 7,526 shares sold on 08/08/2025 by Stephen Hull for $1,327,477.00. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information about the issuer.
Stephen Edward Hull, Sector President at Leidos Holdings, Inc. (LDOS), reported securities transactions on 08/15/2025. The filing shows acquisitions of common stock and related option transactions executed on that date. Specifically, 5,971 shares were acquired at $62.43, 5,387 shares at $107.57 and 1,421 shares at $89.08. Following these transactions the report lists 39,259.9809 shares beneficially owned. The Form 4 was signed under power of attorney on 08/19/2025.
Gary Stephen May, identified as a director of Leidos Holdings, Inc. (LDOS), reported the sale of 2,000 shares of Leidos common stock on 08/11/2025. The sale was executed in multiple transactions at a weighted average price of $178.0522, with individual prices ranging from $177.87 to $178.16. Following the disposition, the reporting person beneficially owned 10,137 shares directly. The Form 4 discloses only this non-derivative disposition; no derivative activity or indication of a 10b5-1 trading plan is shown. The filing was submitted via power of attorney on behalf of the reporting person.
Gregory R. Dahlberg, a director of Leidos Holdings, Inc. (LDOS), filed a Form 4 reporting transactions dated 08/11/2025. The filing discloses exercises of option grants for 1,769 shares at an exercise price of $104.06 and 1,179 shares at an exercise price of $142.66. The issuer withheld shares to cover the exercise price as noted in the form, and 952 shares were sold at a weighted average price of $177.4276. The form lists post-transaction beneficial ownership figures including 22,837, 24,016, 22,020 and 21,068. The Form 4 is signed via power of attorney and dated 08/13/2025.
Stephen Edward Hull, Sector President of Leidos Holdings, Inc. (LDOS), reported a sale of 7,526 shares of common stock on 08/08/2025 at a weighted-average price of $176.3855, with executions ranging from $176.30 to $176.59. The filing lists 26,480.9809 shares as beneficially owned following the transaction, held directly.
The filing explains the reported price is a weighted average from multiple transactions and states the beneficial-ownership total includes shares acquired through the company's Employee Stock Purchase Plan since the last reported transaction. The report was filed by one reporting person.